Solution Phase Synthesis of a Combinatorial Library of Chalcones and Flavones as Potent Cathepsin V Inhibitors Joel Alvim, Jr.,† Richele P. Severino,†,‡ Emerson F. Marques,† Ariane M. Martinelli,† Paulo C. Vieira,† Joa˜o B. Fernandes,† M. Fatima das G. F. da Silva,† and Arlene G. Correˆa*,† Departamento de Quı´mica, UniVersidade Federal de Sa˜o Carlos, 13565-905 Sa˜o Carlos, SP, Brazil, and Departamento de Quı´mica, UniVersidade Federal de Goia´s, 75704-020 Catala˜o, GO, Brazil ReceiVed May 4, 2010 Cathepsin V is a papain-like cysteine protease. It is involved in the control of human T cells (responsible for cell immunity), and presents the largest elastolytic activity among the proteolytic enzymes. Therefore, cathepsin V is a potential molecular target for the treatment of atherosclerosis. In the present work, natural ﬂavonoids were screened against cathepsin V, and two ﬂavones were identiﬁed as potent inhibitors of cathepsin V. On the basis of this result, a combinatorial library of chalcones and ﬂavones was prepared, in solution phase employing a scavenger reagent, and fully evaluated. Introduction Coronary arterial disease is one of the major causes of human death. In this context, atherosclerosis, which is characterized by a thickening and loss of elasticity of the arterial wall, is the leading cause of cardiac illness. Cathepsin V is a papain-like cysteine protease, involved in the control of human T cells (responsible for cell immunity), and presents the largest elastolytic activity among proteolytic enzymes.1,2 It is predominantly expressed in the thymus, testicles, and epithelial corneal. Although cathepsin V can be considered a potential molecular target for the treatment of atherosclerosis, few inhibitors are described in the literature.2,3 The benzopyranone-ring system, found in ﬂavonoids, is a molecular scaffold of considerable interest, and some reports describe this class of compounds as inhibitors of cathepsin acitvity. Kenyon and co-workers reported the activity of chalcone derivatives toward the enzyme cathepsin B.4,5 Patil et al. isolated a new dimeric dihydrochalcone and a preny- lated ﬂavone from Artocarpus altilis (Moraceae) which are potent inhibitors of cathepsin K, with IC50 values of 98 and 840 nM, respectively.6 Pan et al.7 and Zeng et al.8 described biﬂavones isolated from Taxodium mucronatum (Taxodiacea) and Cycas guizhouensis (Cycadaceae) with activity against cathepsin B and K. Bauvois et al. examined the effects of synthetic ﬂavones on a number of metalloproteinases, γ-glutamyl transpeptidase as well as serine proteases such as cathepsin G.9 Medicinal chemistry efforts have focused on diversifying the benzopyranone scaffold and utilizing combinatorial chemistry approaches to construct small benzopyranone libraries.10 In the literature are described several ﬂavonoid libraries synthesized in solution phase, such as, for example, chalcones11–13 and ﬂavones.14,15 Solid-phase organic synthesis (SPOS) has long been an integral component of the synthetic repertoire employed by combinatorial chemists.16 In SPOS, solid support-bound substrates are elaborated synthetically by using an excess of reagents to drive reactions to completion. Desired products can then be isolated easily by simple ﬁltration and removed from the support material. Previous reviews have discussed the importance of combinatorial libraries of ﬂavonoids prepared by solid phase synthesis.17–19 Nicolaou et al. reported a solid-phase synthesis of a 2,2-dimethylbenzopyran motif employing a cycloloading strategy that relies on the use of a polystyrene-based selenenyl bromide resin.20 Harikrishnan and Showalter prepared a small library of isoﬂavone analogues employing a solid-supported diisopro- pylsilyloxy traceless linker.21 Cheng et al. prepared a small library of chalcones via parallel solid phase synthesis.22 A different strategy was employed by Yao et al. for the preparation of a ﬂavone library.23 A functionalized ﬂavone was prepared in solution phase by classical Claisen conden- sation, mixed acid nitration, and oxidative cyclization reac- tion with iodine-dimethyl sulfoxide (DMSO). Then, the ﬂavone was employed as scaffold for the synthesis of a combinatorial library in solid phase. Arai et al. developed an efﬁcient one-pot synthesis by Michael aldol reaction of chromone and ﬂavonoid derivatives bearing heterocyclic units.24 The 2,3-heterocyclic-substituted chromones were obtained in one step. Moreover, the use of substituted benzaldehydes and subsequent addition of heterocyclic aldehydes gave 3-pyridyl-substituted ﬂavones. They have also examined these one-pot reactions in the solid phase by attaching the acetophenone derivative to (4-methoxyphenyl)- diisopropylsilylpropyl polystyrene beads. * Towhomcorrespondenceshouldbeaddressed.E-mail:agcorrea@ufscar.br. Phone: +55-16-33518215. Fax: +55-16-33518281. † Universidade Federal de Sa˜o Carlos. ‡ Universidade Federal de Goia´s. J. Comb. Chem. 2010, 12, 687–695 687 10.1021/cc100076k  2010 American Chemical Society Published on Web 06/25/2010 SPOS has many advantages but also many limiting drawbacks: it can be difﬁcult to adapt conventional solution phase chemistry to a solid-phase format, some solid-phase reactions are signiﬁcantly slower than they are when run in solution, and the progress of solid-phase reactions can be difﬁcult to monitor.11 An alternative is the use of polymer- supported reagents, catalysts, and cleanup agents (scavengers) which facilitate reactions of substrates in solution. For example, a solid-supported reagent can be used to drive to completion a coupling reaction between two reactive sub- strates, one of which is present in excess. A support-bound scavenger can then be used to remove the excess reagent, yielding pure product. Or a support-bound capture reagent can be used to remove the coupling product directly, which is then cleaved from the support.25 Bhat et al. employed a piperazinyl Merriﬁeld resin in the synthesis of a library of ﬂavones.26 Huang et al. described a solid-phase synthesis of ﬂavones employing a Lewis acid-mediated polystyrene- supported selenium induced intramolecular cyclization of chalcones.27 After the oxidative cleavage of selenium resin, the ﬂavones were obtained in good overall yields and high purity. In the present work, we describe the use of tosyl hydrazide scavenger resin in the preparation of a combinatorial library of chalcone and ﬂavone derivatives, identiﬁed as potent inhibitors of cathepsin V. Results and Discussion In an ongoing program toward the development of speciﬁc, potent inhibitors of cathepsin V enzyme, several natural products were screened. The percentage of inhibition was calculated according to the equation: where Vi and V0 are initial velocities (enzyme activities) determined in the presence and in the absence of inhibitor, respectively. Among some other active compounds, a series of ﬂa- vonoids showed interesting activity at initial concentration of 25 µM. The most potent compounds were ﬂavones 1 and 2 (Figure 1), isolated from Vitex polygama (Verbenaceae)28 and Lonchocarpus subglaucescens (Leguminoseae),29 re- spectively, with IC50 ) 2.5 and 13.5 µM. The IC50 values correspond to the concentration of compound required for 50% inhibition of cathepsin V, and were determined from collected data by non-linear regression analysis. On the basis of these results, a small library of ﬂavonoids waspreparedinsolutionphaseemployingtheClaisen-Schmidt condensation,30 followed by oxidative cyclization catalyzed by I2 (Scheme 1).31 The library components were obtained in moderate to good yields and were characterized by 1H NMR and MS. The compounds then were submitted to biochemical evaluation against cathepsin V enzyme (Table 1). In this small series we have already identiﬁed ﬂavone (6d) with a higher inhibition activity than the natural products 1 Figure 1. Natural ﬂavonoids evaluated against cathepsin V. Scheme 1. Synthesis of Flavonoid Derivatives a After chromatographic puriﬁcation. b Chalcone 5b was obtained as a byproduct in the synthesis of chalcone 5e, via a nucleophilic substitution of a ﬂuoride by a methoxy group. c Chalcone 5c was prepared using 50% NaOH in dioxane at 50 °C for 24 h. % inhibition ) 100 × (1 - Vi/V0) 688 Journal of Combinatorial Chemistry, 2010 Vol. 12, No. 5 Alvim, Jr. et al. and 2. To evaluate a larger number of ﬂavonoids and establish some structure-activity relationships, a ﬂavone library was prepared through parallel synthesis using the polystyrene-tosyl hydrazide (PS-Ts-NHNH2) (7) as a car- bonyl scavenging resin.32 Before carrying out the synthesis of the library some tests were realized to optimize the reaction conditions using the resin. The best results were obtained using 0.075 mmol of 2-hydroxy-4-methoxyace- tophenone, 0.1 mmol of resin 7, and 0.1 mmol of 2,4- dimethoxybenzaldehyde, at room temperature for 2 h. The mixture was analyzed by gas chromatography (GC), and the presence of the aldehydes was not observed. Following the reaction conditions previously tested, a library of chalcones and ﬂavones was prepared (Scheme 2) using 4 acetophenones (3) (Figure 2) and 6 aldehydes (4) as building blocks (Figure 3). The diversity of the library was planned based on the structure of natural products 1 and 2, which are highly oxygenated, and also on the commercial availability of reagents. The reactions were carried out in 24 reaction vessels of a Bu¨chi Syncore synthesizer. Initially, for the Claisen-Schmidt condensation, to a solution containing the acetophenone 3 and the aldehyde 4 in methanol was added an aqueous solution of 50% KOH. After 3 h at 75 °C, an aqueous solution of 10% HCl was added to neutralize the mixture. Excess of aldehyde was removed from the reaction mixture by the use of resin scavenger 7 in dimethylformamide (DMF). Oxidative cyclization was carried out in DMSO at 150 °C for 1 h using iodine as catalyst. Thirteen chalcones 5 were puriﬁed by preparative TLC and evaluated against cathepsin V enzyme (Table 2). As observed before, the chalcones showed no activity. The ﬂavones were puriﬁed by SPE or preparative TLC. Analyses Table 1. Inhibitory Activity of a Series of Flavonoids against Cathepsin V compounds inhibition (%) at 25 µM IC50(µM)a 5a 36 >50 5b 14 >50 5c 64 >50 6a ndb nd 6b 18 >50 6c nd nd 6d 100 1.2 ( 0.1 6e 19 >50 a The values represent the mean values of three individual experiments ( SD. b nd ) not determinate because compound showed ﬂuorescence superior of the control. Scheme 2. Synthetic Route for Preparation the Combinatorial Library Figure 2. Acetophenones 3 employed in the synthesis of the combinatorial library. Figure 3. Aldehydes 4 employed in the synthesis of the combina- torial library. Table 2. Inhibitory Activity of a Series of Chalcones 5 against Cathepsin V chalcone R1 R2 R3 R4 R5 R6 inhibition (%)a 5{1,1} BnO H H H H MeO 21 5{1,3} BnO H H MeO MeO MeO 35 5{1,4} BnO H H H H CF3O 22 5{2,1} MeO H MeO H H MeO 24 5{2,2} MeO H MeO MeO H MeO 22 5{2,3} MeO H MeO MeO MeO MeO 1 5{2,6} MeO H MeO H H C6H5 57 5{3,1} H F H H H MeO 53 5{3,4} H F H H H CF3O 26 5{3,6} H F H H H C6H5 48 5{4,6} H MeO H H H C6H5 7 a All compounds were tested at 25 µM and showed IC50 > 50 µM. Combinatorial Library of Chalcones and Flavones Journal of Combinatorial Chemistry, 2010 Vol. 12, No. 5 689 by HPLC in three different wavelengths (254, 280, and 320 nm) showed that 21 ﬂavones 6 were prepared in low to moderate yield (13-68%) and good to high purity (80-95%). All compounds were characterized by 1H and 13C NMR, and the spectroscopic data were compared with those reported in the literature.33–57 The library components were submitted to biochemical evaluation (Table 3). The ﬁrst aspect of the validation of these results was the analysis of false positives. Depending on the assay design and detection method used for the screening assay, various artifacts can occur that lead to wrong results. Before performing the screening, all compounds were analyzed on a ﬂuorimeter using the test conditions without the addition of the enzyme. Flavones 6a, 6c, 6{1,2}, 6{2,4}, and 6{4,4} showed intrinsic ﬂuorescence; thus, it was not possible to verify their potency as inhibitors. Compounds that inhibited more than 50% were selected for determination of IC50 values. When diluted, ﬂavones 6{1,1}, 6{1,3}, and 6{2,1} showed ﬂuorescence above the control, suggesting that at lower concentrations these compounds may cause a confor- mational change of the protein, and it was not possible to observe the ﬂuorescence quenching, thus interfering with the response of the test. Most of the ﬂavones showed signiﬁcant inhibition with IC50 values varying in the range of 0.8-25.1 µM. Primary studies on the structure-activity relationships (SAR) of the ﬂavonoids suggest the importance of the ring C. Interestingly the chalcones exhibited lower inhibition in a unique con- centration demonstrating that cyclization to form the C ring is relevant to interaction between enzyme site and inhibitor. We also observed that among the most potent compounds, ﬂavones 6d, 6{3,1}, and 6{3,2} (IC50 ) 1.2, 0.8, and 1.6 µM, respectively) possess one halogen (bromine or ﬂuorine) as substituent in the A ring and methoxy groups in the C ring. In conclusion, despite the lack of a detailed experimental enzyme-inhibitor complex, from the natural products screen- ing, we have been able to identify synthetic ﬂavones with increased potency. These results indicate the potential of this class as promising inhibitors of cathepsin V. To further investigate these results and thus generate useful data for the computer aided molecular design, modeling studies are being performed through docking protocol. 3. Experimental Section All commercially available reagents were purchased from Aldrich Chemical Co. Reagents and solvents were puriﬁed when necessary according to the usual procedures described in the literature. 1H and 13C NMR spectra were recorded on a Bruker ARX-200 (200 and 50 MHz respectively). The IR spectra refer to ﬁlms and were measured on a Bomem M102 spectrometer. Mass Spectra were recorded on a Shimadzu GCMS-QP5000. Analytical thin-layer chromatography was performed on a 0.25 µm ﬁlm of silica gel containing ﬂuorescent indicator UV254 supported on an aluminum sheet (Sigma-Aldrich). Flash column chromatography was per- formed using silica gel (Kieselgel 60, 230-400 mesh, E. Merck). Gas chromatography was performed in a Shimadzu GC-17A with H2 as carrier and using a DB-5 column. Solid- phase extraction (SPE) was carried out using silica cartridges (Phenomenex Strata Silica SL-1, 500 mg, 6 mL). HPLC analyses were performed in Shimadzu equipment with a LC- 20AT pump, SIL-10A injector, SPD-20A detector, and in a Phenomenex column Luna C18(2) 5 µm (150 × 4.6 mm). The combinatorial library was prepared in a Syncore Bu¨chi synthesizer. General Procedure for the Synthesis of Chalcones 5a-e. To a solution of acetophenone 3 and aldehyde 4 in methanol was added an aqueous solution of KOH 50% (Table 5). The mixture was stirred at 70 °C for 3 h, and Table 3. Synthesis and Evaluation of the Flavone Combinatorial Library ﬂavones R1 R2 R3 R4 R5 R6 yield (%) purity (%) inhibition (%) at 25 µM IC50(µM)a 6{1,1} BnO H H H H MeO 68 >95c 100 ndd 6{1,2} BnO H H MeO H MeO 46 >95 nd nd 6{1,3} BnO H H MeO MeO MeO 38 >95 52 nd 6{1,4} BnO H H H H CF3O 60 >95 56 2.7 ( 0.3 6{1,5} BnO H H H O-CH2-O 42 >95 100 1.5 ( 0.2 6{1,6} BnO H H H H C6H5 29 >80 85 11.1 ( 1.0 6{2,1} MeO H MeO H H MeO 30 >95 100 nd 6{2,2} MeO H MeO MeO H MeO 13 >95 56 19.0 ( 1.8 6{2,3} MeO H MeO MeO MeO MeO 25 >95 6 >50 6{2,4} MeO H MeO H H CF3O 68 >95 nd nd 6{2,5} MeO H MeO H O-CH2-O 35 >95 51 25.1 ( 2.2 6{2,6} MeO H MeO H H C6H5 50 >90 26 >50 6{3,1} H F H H H MeO 52 >95 100 0.8 ( 0.05 6{3,2} H F H MeO H MeO 68 >90 100 1.6 ( 0.2 6{3,3} H F H MeO MeO MeO 25 >95 84 4.1 ( 0.4 6{3,4} H F H H H CF3O b 6{3,5} H F H H O-CH2-O b 6{3,6} H F H H H C6H5 66 >95 74 2.9 ( 0.3 6{4,1} H MeO H H H MeO 43 >95 100 12.0 ( 0.9 6{4,2} H MeO H MeO H MeO 24 >95 30 >50 6{4,3} H MeO H MeO MeO MeO 24 >95 35 >50 6{4,4} H MeO H H H CF3O 31 >90 nd nd 6{4,5} H MeO H H O-CH2-O b 6{4,6} H MeO H H H C6H5 33 >90 65 19.2 ( 1.8 a The values represent means of at three individual experiments ( SD. b Product not obtained. c Analysis by HPLC at three different wavelengths (254, 280, and 320 nm). d nd ) not determinate because the solution showed ﬂuorescence superior of the control. 690 Journal of Combinatorial Chemistry, 2010 Vol. 12, No. 5 Alvim, Jr. et al. then an aqueous solution of HCl 10% was added. The organic layer was extracted with ethyl acetate, dried with Na2SO4, and concentrated under vacuum. The crude product was puriﬁed by ﬂash column chromatography in silica gel or by recrystallization. 2′-Hydroxy-2,4,4′-trimethoxychalcone (5a).33 mp: 153- 155 °C. 1H NMR (200 MHz, CDCl3) δ: 3.84 (s, 3H); 3.85 (s, 3H); 3.91 (m, 3H); 6.42-6.50 (m, 3H); 6.53 (dd, J ) 8.5, 2.3 Hz, 1H); 7.56 (d, J ) 8.5 Hz, 1H); 7.60 (d, J ) 15.5 Hz, 1H); 7.75-7.89 (m, 1H); 8.12 (d, J ) 15.5 Hz, 1H); 13.69 (s, 1H). 13C NMR (50 MHz, CDCl3) δ: 55.5; 55.7; 98.5; 101.0; 105.4; 107.4; 114.4; 117.1; 118.4; 131.1; 140.2; 160.5; 163.2; 165.8; 166.5; 192.5. MS m/z: 314 (M+), 299, 283, 257, 240, 211, 191, 177, 164, 151 (100), 149, 121, 108, 91, 77, 51. IR (νmax, KBr): 2935, 1627, 1608, 1558, 1506, 1216, 1153, 1020, 835 cm-1. 2-Chloro-4′-ﬂuoro-2′-hydroxy-6-methoxychalcone (5b). mp: 133-135 °C. 1H NMR (200 MHz, CDCl3) δ: 3.98 (s, 3H); 6.57-6.78 (m, 2H); 6.90 (d, J ) 8.1 Hz, 1H); 7.10 (dd, J ) 8.1, 1.2 Hz, 1H); 7.28 (t, J ) 8.1, 1H); 7.88 (dd, J ) 8.8, 6.4 Hz, 1H); 8.03 (d, J ) 15.8 Hz, 1H); 8.26 (d, J ) 15.8 Hz, 1H); 13.26 (d, J ) 1.6 Hz, 1H). 13C NMR (50 MHz, CDCl3) δ: 56.0; 105.0 (d, J ) 23.4 Hz); 107.0 (d, J ) 22.5 Hz); 109.7; 117,2 (d, J ) 2.0 Hz); 121.8; 122.6; 125.4; 131.1; 132.1 (d, J ) 11.5 Hz); 137.1; 137.8; 160.2; 166.1; 167.3 (d, J ) 254.8 Hz); 193.6. MS m/z: 308 (M+ +2), 306 (M+), 271, 256, 199, 165, 139, 125, 111, 103, 89, 83 (100), 63, 57. IR (νmax, KBr): 1635, 1598, 1560, 1469, 1351, 1268, 1205, 1043, 836 cm-1. 4′-Benzyloxy-2′-hydroxy-3-methoxychalcone (5c).34 mp 131-132 °C. 1H NMR (200 MHz, CDCl3) δ: 3.86 (s, 3H); 5.11 (s, 2H); 6.52-6.62 (m, 2H); 6.97 (ddd, J ) 8.0, 2.5, 1.2 Hz, 1H); 7.13-7.19 (m, 1H); 7.20-7.28 (m, 1H); 7.29-7.36 (m, 1H); 7.37-7.48 (m, 5H); 7.55 (d, J ) 15.5 Hz, 1H); 7.85 (d, J )15 Hz, 1H); 7.78-7.93 (m, 1H); 13.39 (s, 1H). 13C NMR (50 MHz, CDCl3) δ: 55.4; 70.2; 102.2; 108.2; 113.6; 114.3; 116.4; 120.7; 121.2; 127.5; 128.3; 128.7; 130.0; 131.3; 135.9; 136.2; 144.4; 160.0; 165.3; 166.6; 191.8. MS m/z: 360 (M+), 235, 134, 91 (100), 51. IR (νmax, KBr): 2923, 1639, 1619, 1573, 1251, 1132, 1037, 850, 736 cm-1. 5′-Bromo-2′-hydroxy-2,4-dimethoxychalcone (5d). mp 116-118 °C. 1H NMR (200 MHz, CDCl3) δ: 3.87 (s, 3H); 3.93 (s, 3H); 6.48 (d, J ) 2.4 Hz, 1H); 6.56 (dd, J ) 8.8, 2.4 Hz, 1H); 6.91 (d, J ) 8.8 Hz, 1H); 7.53 (dd, J ) 8.8, 2.4 Hz, 1H); 7.57 (d, J ) 15.4 Hz, 1H); 7.61 (d, J ) 8.8 Hz, 1H); 7.99 (d, J ) 2.4 Hz, 1H); 8.19 (d, J ) 15.4 Hz, 1H); 13.0 (s, 1H). 13C NMR (50 MHz, CDCl3) δ: 55.5; 55.7; 98.5; 105.8; 110.2; 116.7; 117.3; 120.5; 121.6; 131.6; 131.8; 138.3; 142.3; 160.9; 162.4; 163.8; 193.2. MS m/z: 364 (M+ + 1), 362 (M+ - 1), 333, 331, 225, 201, 199, 164, 149 (100), 138, 121, 105, 91, 77, 63, 51. IR (νmax, KBr): 2925, 1850, 1751, 1616, 1558, 1506, 1419, 1267, 1162, 1027, 819 cm-1. 2-Chloro-4′,6-diﬂuoro-2′-hydroxychalcone (5e). mp 126-128 °C. 1H NMR (200 MHz, CDCl3) δ: 6.55-6.82 (m, 2H); 7.01-7.18 (m, 1H); 7.20-7.42 (m, 2H); 7.75-7.97 (m, 2H); 8.12 (d, J ) 15.8 Hz, 1H); 13.08 (d, J ) 1.4 Hz, 1H). 13C NMR (50 MHz, CDCl3) δ: 105.1 (d, J ) 23.4 Hz); 107.3 (d, J ) 22.6 Hz); 114.9 (d, J ) 23.4 Hz); 117.0 (d, J ) 2.0 Hz); 121.8 (d, J ) 13.6 Hz); 126.2 (d, J ) 3.7 Hz); 126.6 (d, J ) 14.4 Hz); 131.2 (d, J ) 10.6 Hz); 132.2 (d, J ) 11.9 Hz); 135.3 (d, J ) 2.0 Hz); 136.8 (d, J ) 5.3 Hz); 162.2 (d, J ) 254.8 Hz); 165.6 (d, J ) 54.0 Hz); 168.2 (d, J ) 187.2 Hz); 192.7. MS m/z: 296 (M++2), 294 (M+), 277, 259, 201, 183, 165, 139, 120, 110, 99, 83, 57 (100). IR (νmax, KBr): 1652, 1602, 1506, 1457, 1419, 1353, 1270, 1214, 921, 850, 775 cm-1. General Procedure for the Synthesis of Flavones 6a-e. To a solution of chalcone 5a-e in DMSO was added iodine (Table 4). The mixture was stirred for 20 min at 190 °C, and then water was added. The organic layer was extracted with ethyl acetate, washed with an aqueous solution of 0.1 M sodium thiosulfate and brine, then dried with Na2SO4 and concentrated under vacuum. The crude product was puriﬁed by ﬂash column chromatography in silica gel or by recrystallization. 2′,4′,7-Trimethoxyﬂavone (6a).35 mp 133-134 °C. 1H NMR (200 MHz, CDCl3) δ: 3.88 (s, 3H); 3.91 (s, 6H); 6.55 (d, J ) 2.3 Hz, 1H); 6.62 (dd, J ) 8.7, 2.3 Hz, 1H); 6.90 (dd, J ) 2.4, 0.4 Hz, 1H); 6.95 (dd, J ) 8.7, 2.4 Hz, 1H); 7.06 (s, 1H); 7.86 (d, J ) 8.7 Hz, 1H); 8.12 (dd, J ) 8.7, 0.4 Hz, 1H). 13C NMR (50 MHz, CDCl3) δ: 55.5; 55.6; 55.7; 98.9; 100.3; 105.2; 111.2; 113.7; 113.9; 117.7; 126.9; 130.3; 158.1; 159.5; 160.4; 163.1; 163.9; 178.4. MS m/z: 312 (M+), 162, 151 (100), 142, 119, 91, 65. IR (νmax, KBr): 2923, 1623, 1440, 1263, 1162, 1027, 833 cm-1. 2′-Chloro-7′-ﬂuoro-6′-methoxyﬂavone (6b). mp 167- 169 °C. 1H NMR (200 MHz, CDCl3) δ: 3.82 (s, 3H); 6.40 (s, 1H); 6.93 (dd, J ) 8.4, 0.8 Hz, 1H); 7.07-7.22 (m, 3H); Table 4. Preparation of Chalcones 5a-e acetophenone (mg/mmol) aldehyde (mg/mmol) KOH 50% (mL) MeOH (mL) product (mg) yield (%) 100/0.60 150/0.90 0.90 4.2 5a (60) 32 100/0.65 133/0.84 0.84 4.5 5b (99) 50 5e (27) 14 107/0.44 63/0.46 10a 10b 5c (113) 71 70/0.32 70/0.42 0.42 2.1 5d (81) 70 a 50% NaOH was used as base. b 1,4-Dioxane was employed as solvent. Table 5. Preparation of Flavones 6a-e chalcone (mg/mmol) I2(mg) DMSO (mL) product (mg) yield (%) 5a (30/0.09) 1.0 1.3 6a (24) 80 5b (15/0.05) 1.0 0.7 6b (9) 62 5c (50/0.14) 1.0 1.7 6c (41) 82 5d (60/0.16) 2.8 2.0 6d (43) 75 5e (22/0.08) 1.0 1.0 6e (11) 50 Combinatorial Library of Chalcones and Flavones Journal of Combinatorial Chemistry, 2010 Vol. 12, No. 5 691 7.41 (t, J ) 8.4, 1H); 8.22-8.34 (m, 1H). 13C NMR (50 MHz, CDCl3) δ: 55.2; 104.9 (d, J ) 25.1 Hz); 109.6; 113.8 (d, J ) 22.6 Hz); 115.0; 120.9 (d, J ) 1.8 Hz); 121.5; 121.9; 128.2 (d, J ) 10.5 Hz); 132.1; 134.6; 158.0 (d, J ) 13.4 Hz); 158.5; 160.4; 165.6 (d, J ) 253.0 Hz); 177.2. MS m/z: 306 (M+ +2), 304 (M+), 269, 254, 165, 165, 139 (100), 110, 82. IR (νmax, KBr): 2925, 2836, 1623, 1562, 1506, 1475, 1353, 1299, 1268, 1143, 1052, 1027, 896, 846, 792 cm-1. 7-Benzyloxy-3′-methoxyﬂavone (6c).34 mp 155-157 °C. 1H NMR (200 MHz, CDCl3) δ: 3.85 (s, 3H); 5.18 (s, 2H); 6.74 (s, 1H); 7.02-7.06 (m, 2H); 7.06-7.11 (m, 1H); 7.34-7.53 (m, 8H); 8.13 (ddd, J ) 8.8, 1.1, 1.1 Hz, 1H). 13C NMR (50 MHz, CDCl3) δ: 55.5; 70.5; 101.5; 107.8; 111.7; 114.9; 117.0; 118.1; 118.6; 127.1; 127.5; 128.4; 128.8; 130.1; 133.2; 135.7; 157.9; 160.0; 162.8; 163.3; 177.8. MS m/z: 358 (M+), 139, 102, 91 (100), 63. IR (νmax, KBr): 2921, 1639, 1602, 1440, 1238, 1033, 854, 696 cm-1. 6-Bromo-2′,4′-dimethoxyﬂavone (6d).36 mp 185-188 °C. 1H NMR (200 MHz, CDCl3) δ: 3.89 (s, 3H); 3.92 (s, 3H); 6.54 (d, J ) 2.4 Hz, 1H); 6.62 (dd, J ) 8.8, 2.4 Hz, 1H); 7.15 (s, 1H); 7.39 (dd, J ) 8.8, 0.4 Hz, 1H); 7.72 (dd, J ) 8.8, 2.4 Hz, 1H); 7.86 (d, J ) 8.8 Hz, 1H); 8.23 (dd, J ) 2.4, 0.4 Hz, 1H). 13C NMR (50 MHz, CDCl3) δ: 55.5; 55.7; 98.9; 105.4; 111.2; 113.1; 118.1; 119.8; 125.1; 128.2; 130.4; 136.2; 155.1; 159.8; 161.0; 163.5; 177.4. MS m/z: 362 (M+ +1), 360 (M+ -1), 201, 199, 162, 147, 119, 91, 63 (100). IR (νmax, KBr): 1623, 1562, 1475, 1353, 1299, 1268, 1143, 1052, 846, 792 cm-1. 2′-Chloro-6′,7-diﬂuoroﬂavone (6e). mp 167-168 °C. 1H NMR (200 MHz, CDCl3) δ: 6.50 (s, 1H); 7.00-7.25 (m, 3H); 7.29-7.55 (m, 2H); 8.20-8.35 (m, 1H). 13C NMR (50 MHz, CDCl3) δ: 104.9 (d, J ) 25.2 Hz); 114.5 (d, J ) 46.2 Hz); 114.9 (d, J ) 42.6 Hz); 115.0 (d, J ) 42.6 Hz); 120.7 (d, J ) 2.8 Hz); 120,9 (d, J ) 13.5 Hz); 122.2; 125.9 (d, J ) 3.5 Hz); 128.3 (d, J ) 10.6 Hz); 132.5 (d, J ) 9.4 Hz); 134.5 (d, J ) 3.0 Hz); 157.5 (d, J ) 9.4 Hz); 160.4 (d, J ) 253.3 Hz); 165.8 (d, J ) 253.9 Hz); 176.8. MS m/z: 294 (M+ +2), 292 (M+), 266, 264, 201, 181, 154, 138, 110 (100), 100, 82, 63, 57. IR (νmax, KBr): 2925, 2854, 1660, 1625, 1446, 1371, 1257, 1147, 1033, 854, 788 cm-1. Synthesis of the Combinatorial Library of Flavones 6. In 24 reaction vessels of a Bu¨chi Syncore synthesizer was placed a solution of acetophenone 3{1-4} (0.075 mmol) and aldehyde 4{1-6} (0.10 mmol) (Figure 2) in methanol (2.0 mL). Then it was added an aqueous solution of KOH 50% (150 µL). The mixture was stirred at 75 °C for 3 h, and then an aqueous solution of HCl 10% (750 µL) was added. The solvent was evaporated, then ethyl acetate (3 mL) was added and the organic layer was transferred to another vessel. This procedure was repeated three times and then concentrated under vacuum. Then DMF (1 mL) was added followed by PS-Ts-NHNH2 (7) (50 mg, 0.1 mmol). The mixture was stirred for 2 h at room temperature, then it was washed with methylene chloride (3 mL), and the organic layer was transferred to another vessel. This procedure was repeated three times; then the solvent was evaporated furnishing chalcones 5. One third was separated for further character- ization and bioassays. To the previously prepared chalcones 5 was added a 1 mg/mL solution of iodine in DMSO (1 mL). The mixture was stirred for 1 h at 150 °C, and then an aqueous solution of 0.1 M sodium thiosulfate (0.1 mL) was added. The mixture was concentrated under vacuum, and the crude product was puriﬁed by SPE using silica gel (500 mg) and methylene chloride: ethyl acetate (8:2) or preparative TLC using hexane: ethyl acetate (8:2) as eluent. The ﬂavones 6 were analyzed by HPLC (see Table 3), characterized by 1H and 13C NMR, and evaluated against cathepsin V enzyme. 4′-Benzyloxy-2′-hydroxy-4-methoxychalcone (5{1,1}).37 1H NMR (200 MHz, CDCl3) δ: 3.86 (s, 3H); 5.11 (s, 2H); 6.47-6.62 (m, 2H); 6.94 (d, J ) 8.6 Hz, 2H); 7.30-7.53 (m, 6H); 7.61 (d, J ) 8.6 Hz, 2H); 7.82 (d, J ) 2.8 Hz, 1H); 7.88 (d, J ) 8.7 Hz, 1H); 13.52 (s, 1H). 4′-Benzyloxi-2′-hydroxy-2,4,6-trimethoxychalcone (5{1,3}).38 1H NMR (200 MHz, CDCl3) δ: 3.90 (s, 3H); 3.92 (s, 3H); 3.97 (s, 3H); 5,11 (s, 2H); 6.50-6.62 (m, 2H); 6.73 (d, J ) 8.9 Hz, 1H); 7.31-7.52 (m, 6H); 7.63 (d, J ) 15.6 Hz, 1H); 7.78-7.90 (m, 1H); 8.05 (d, J ) 15.6 Hz, 1H); 13.56 (s, 1H). 4′-Benzyloxy-2′-hydroxy-4-triﬂuoromethoxychal- cone (5{1,4}). 1H NMR (200 MHz, CDCl3) δ: 5.12 (s, 2H); 6.52-6.64 (s, 2H); 7.25-7.32 (m, 1H); 7.35-7.47 (m, 5H); 7.54 (J ) 15.5 Hz, 1H); 7.63-7.75 (m, 2H); 7.84 (d, J ) 9.5 Hz, 1H); 7.86 (J ) 15.5 Hz, 1H); 13.32 (s, 1H). 2′-Hydroxy-4,4′,6′-trimethoxychalcone (5{2,1}):39 1H NMR (200 MHz, CDCl3) δ: 3.84 (s, 3H); 3.85 (s, 3H); 3.92 (s, 3H); 5.97 (d, J ) 2.4, 1H); 6.11 (d, J ) 2.4 Hz, 1H); 6.87-7.02 (m, 2H); 7.51-7.63 (m, 2H); 7.80 (s, 2H); 14.40 (s, 1H). 2′-Hydroxy-2,4,4′,6′-tetramethoxychalcone (5{2,2}).40 1H NMR (200 MHz, CDCl3) δ: 3.83 (s, 3H); 3.86 (s, 3H); 3.90 (s, 3H); 3.91 (s, 3H); 5.96 (dd, J ) 2.4, 0.2 Hz, 1H); 6.10 (d, J ) 2.4 Hz, 1H); 6.47 (dd, J ) 2.4, 0.3 Hz, 1H); 6.53 (ddd, J ) 8.5, 2.3, 0.3 Hz, 1H); 7.55 (d, J ) 8.5 Hz, 1H); 7.90 (d, J ) 15.6 Hz, 1H); 8.11 (d, J ) 15.6 Hz, 1H); 14.54 (s, 1H). 2′-Hydroxy-2,3,4,4′,6′-pentamethoxychalcone (5{2,3}).41 1H NMR(200 MHz, CDCl3) δ: 3.84 (s, 3H); 3.89 (s, 3H); 3.91 (s, 3H); 3.95 (s, 3H); 5.96 (d, J ) 2.4, 1H); 6.11 (d, J ) 2.4 Hz, 1H); 6.72 (d, J ) 8.8 Hz, 1H); 7.35 (d, J ) 8.8 Hz, 1H); 7.90 (d, J ) 15.8 Hz, 1H); 8.02 (d, J ) 15.8 Hz, 1H); 14.44 (s, 1H). 4-Phenyl-2′-hydroxy-4′,6′-dimethoxychalcone (5{2,6}). 1H NMR (200 MHz, CDCl3) δ: 3.85 (s, 3H); 3.94 (s, 3H); 5.98 (d, J ) 2.3 Hz, 1H); 6.12 (d, J ) 2.3 Hz, 1H); 7.35-7.55 (m, 3H); 7.57-7.75 (m, 6H); 15.65 (d, J ) 15.7 Hz, 1H); 7.96 (d, J ) 15.4 Hz, 1H); 14.32 (s, 1H). 5′-Fluoro-2′-hydroxy-4-methoxychalcone (5{3,1}).42 1H NMR (200 MHz, CDCl3) δ: 3.88 (s, 3H); 6.91-7.06 (m, 3H); 7.17-7.32 (m, 1H); 7.42 (d, J ) 15.4 Hz, 1H); 7.52-7.2 (m, 3H); 7.93 (d, J ) 15.4 Hz, 1H); 12.65 (s, 1H). 5′-Fluoro-2′-hydroxy-2,4-dimethoxychalcone (5{3,2}). mp 106-107 °C. 1H NMR (200 MHz, CDCl3) δ: 3.87 (s, 3H); 3.93 (s, 3H); 6.48 (d, J ) 2.2 Hz, 1H); 6.55 (dd, J ) 8.5, 2.2 Hz, 1H); 6.97 (dd, J ) 9.0, 4.8 Hz, 1H); 7.14-7.32 (m, 1H); 7.52-7.67 (m, 3H); 8.18 (d, J ) 15.6 Hz, 1H); 12.81 (s, 1H). 13C NMR (50 MHz, CDCl3) δ: 55.5; 55.6; 692 Journal of Combinatorial Chemistry, 2010 Vol. 12, No. 5 Alvim, Jr. et al. 98.5; 105.7; 114.5 (d, J ) 23.1 Hz); 116.7; 117.5; 119.6 (d, J ) 7.0 Hz); 119.9 (d, J ) 6.2 Hz); 123.2 (d, J ) 23.5 Hz); 131.8; 142.2; 154.8 (d, J ) 237.5 Hz); 159.6 (d, J ) 1.6 Hz); 160.9; 163.7; 193 (d, J ) 2.8 Hz). MS m/z: 302 (M+), 287, 271, 245, 199, 164, 149 (100), 147, 133, 121, 110, 83, 77, 57, 51. IR (νmax, KBr): 2952, 2917, 2848, 1635, 1558, 1506, 1471, 1457, 1290, 1180, 1024, 823, 808 cm-1. 5′-Fluoro-2′-hydroxy-2,3,4-trimethoxychalcone (5{3,3}). 1H NMR (200 MHz, CDCl3) δ: 3.90 (s, 3H); 3.93 (s, 3H); 3.99 (s, 3H); 6.74 (d, J ) 8.8 Hz, 1H); 6.99 (dd, J ) 9.1, 4.6 Hz, 1H); 7.14-7.33 (m, 1H); 7.40 (d, J ) 8.8, 1H); 7.57 (dd, J ) 9.1, 3.1 Hz, 1H); 7.60 (d, J ) 15.6 Hz, 1H); 8.12 (d, J ) 15.6 Hz, 1H); 12.69 (s, 1H). 5′-Fluoro-2′-hydroxy-3,4-methylenedioxychalcone (5{3,5}).43 1H NMR (200 MHz, CDCl3) δ: 6.06 (s, 2H); 6.82-6.92 (m, 1H); 6.99 (dd J ) 9.1, 4.7 Hz, 1H); 7.12-7.23 (m, 3H); 7.37 (d, J ) 15.3, 1H); 7.56 (dd, J ) 9.1, 3.0 Hz, 1H); 7.87 (d, J ) 15.3 Hz, 1H); 12.60 (s, 1H). 4-Phenyl-5′-ﬂuoro-2′-hydroxychalcone (5{3,6}). 1H NMR (200 MHz, CDCl3) δ: 7.01 (dd, J ) 9.1, 4.7 Hz, 1H); 7.30-7.50 (m, 4H); 7.51-7.83 (m, 8H); 8.00 (d, J ) 15.5 Hz, 1H); 12.56 (s, 1H). 4-Phenyl-2′-hydroxy-5′-methoxychalcone (5{4,6}).44 1H NMR (200 MHz, CDCl3) δ: 3.86 (s, 3H); 6.99 (d, J ) 9.1 Hz, 1H); 7.16 (dd, J ) 9.1, 3.0 Hz, 1H); 7.32-7.55 (m, 5H); 7.56-7.87 (m, 6H); 7.98 (d, J ) 15.5 Hz, 1H); 12.40 (s, 1H). 7-Benzyloxy-4′-methoxyﬂavone (6{1,1}).45 1H NMR (200 MHz, CDCl3) δ: 3.88 (s, 3H); 5.18 (s, 2H); 6.69 (s, 1H); 6.96-7.10 (m, 4H); 7.32-7.55 (m, 5H); 7.77-7.92 (m, 2H); 8.10-8.18 (m, 1H). 13C NMR (50 MHz, CDCl3) δ: 55.5; 70.5; 101.5; 106.1; 114.4; 114.7; 117.9; 124.1; 127.1; 127.4; 127.8; 128.3; 128.7; 135.8; 157.8; 162.3; 163.1; 163.2; 177.8. 7-Benzyloxy-2′,4′-dimethoxyﬂavone (6{1,2}). 1H NMR (200 MHz, CDCl3) δ: 3.89 (s, 3H); 3.92 (s, 3H); 5.17 (s, 2H); 6.56 (d, J ) 2.3 Hz, 1H); 6.62 (dd, J ) 8.7, 2.3 Hz, 1H); 6.99 (d, J ) 2.3 Hz, 1H); 7.04 (dd, J ) 8.7, 2.3 Hz, 1H); 7.05 (s, 1H); 7.33-7.54 (m, 5H); 7.84 (d, J ) 8.7 Hz, 1H); 8.14 (d, J ) 8.7 Hz, 1H). 13C NMR (50 MHz, CDCl3) δ: 55.6; 55.7; 70.5; 99.9; 101.4; 105.3; 111.3; 113.8; 114.5; 117.9; 127.1; 127.5; 128.4; 128.8; 130.3; 135.9; 158.0; 159.6; 161.6; 163.0; 163.1, 178.4. 7-Benzyloxy-2′,4′,6′-trimethoxyﬂavone (6{1,3}). 1H NMR (200 MHz, CDCl3) δ: 3.91 (s, 3H); 3.94 (s, 6H); 5.18 (s, 2H); 6.79 (d, J ) 8.9 Hz, 1H); 6.91 (s, 1H); 6.98 (d, J ) 2.4 Hz, 1H); 7.06 (dd, J ) 8.9, 2.4 Hz, 1H); 7.33-7.46 (m, 5H); 7.51 (d, J ) 8.9 Hz, 1H); 8.15 (d, J ) 8.9 Hz, 1H). 13C NMR (50 MHz, CDCl3) δ: 56.1; 61.0; 61.2; 70.5; 101.5; 107.4; 111.1; 114.6; 118.0; 119.2; 124.0; 127.2; 127.5; 128.4; 128.8; 135.8; 142.9; 153.0; 156.1; 158.0; 161.1, 163.1, 178.1. 7-Benzyloxy-4′-triﬂuoromethoxyﬂavone (6{1,4}). 1H NMR (200 MHz, CDCl3) δ: 5.20 (s, 2H); 6.74 (s, 1H); 7.01-7.13 (m, 2H); 7.31-7.55 (m, 7H); 7.87-8.01 (m, 2H); 8.14 (d, J ) 8.7 Hz, 1H). 13C NMR (50 MHz, CDCl3) δ: 70.7; 101.6; 108.0; 115.1; 118.0; 120.4 (d, J ) 258.6 Hz); 121.1 (q, J ) 1.0 Hz); 127.3; 127.5; 127.9; 128.5; 130.4; 135.7; 151.4 (q, J ) 2.0 Hz); 157.9; 161.7; 163.4, 177.6. 7-Benzyloxy-4′-piperonylﬂavone (6{1,5}).46 1H NMR (200 MHz, CDCl3) δ: 5.18 (s, 2H); 6.07 (s, 2H); 6.64 (s, 1H); 6.92 (dd, J ) 8.2, 0.3 Hz, 1H); 7.01 (d, J ) 2.4 Hz, 1H); 7.05 (dd, J ) 8.7, 2.4 Hz, 1H); 7.33 (dd, J ) 1.8, 0.3 Hz, 1H); 7.35-7.47 (m, 5H); 7.49 (d, J ) 1.8 Hz, 1H); 8.13 (d, J ) 8.7 Hz, 1H). 13C NMR (50 MHz, CDCl3) δ: 70.5; 101.5; 101.9; 106.2; 106.6; 108.7; 114.8; 118.0; 121.3; 125.8; 127.1; 127.5; 128.4; 128.7; 135.8; 148.4; 150.5; 157.8; 162.2; 163.2; 177.7. 7-Benzyloxy-4′-phenylﬂavone (6{1,6}).47 1H NMR (200 MHz, CDCl3) δ: 5.20 (s, 2H); 6.82 (s, 1H); 7.02-7.13 (m, 2H); 7.34-7.55 (m, 8H); 7.60-7.69 (m, 2H); 7.70-7.79 (m, 2H); 7.93-8.04 (m, 2H); 8.15-8.21 (m, 1H). 13C NMR (50 MHz, CDCl3) δ: 70.6; 101.5; 107.4; 114.9; 118.0; 126.7; 127.1; 127.2; 127.5; 127.6; 128.1; 128.4; 128.8; 129.0; 130.5; 135.7; 139.8; 144.3; 157.9; 162.9; 163.3; 177.9. 4′,5,7-Trimethoxyﬂavone (6{2,1}).50 1H NMR (200 MHz, CDCl3) δ: 3.88 (s, 3H); 3.91 (s, 3H); 3.95 (s, 3H); 6.37 (d, J ) 2.3, 1H); 6.56 (d, J ) 2.3 Hz, 1H); 6.59 (s, 1H); 6.95-7.05 (m, 2H); 7.77-7.87 (m, 2H). 13C NMR (50 MHz, CDCl3) δ: 55.5; 55.7; 56.4; 92.9; 96.2; 107.8; 109.3; 114.5; 124.0; 127.7; 159.9; 160.7; 161.0; 162.1; 164.4; 177.6. 5,7-Dimethoxy-2′,4′-dimethoxyﬂavone (6{2,2}).49 1H NMR (200 MHz, CDCl3) δ: 3.88 (s, 3H); 3.89 (s, 3H); 3.91 (s, 3H); 3.95 (s, 3H); 6.36 (d, J ) 2.2, 1H); 6.52 (d, J ) 2.2 Hz, 1H); 6.54 (d, J ) 2.3 Hz, 1H); 6.61 (dd, J ) 8.7 and 2.3 Hz, 1H); 6.98 (s, 1H); 7.84 (d, J ) 8.7 Hz, 1H). 13C NMR (50 MHz, CDCl3) δ: 55.3; 55.6; 55.7; 56.4; 92.7; 95.8; 98.8; 105.1; 112.8; 113.4; 114.3; 130.0; 158.1; 159.5; 160.0; 160.8; 162.9; 163.7; 178.2. 2′,3′,4′,5,7-Pentamethoxyﬂavone (6{2,3}).50 1H NMR (200 MHz, CDCl3) δ: 3.89 (s, 3H); 3.90 (s, 3H); 3.93 (s, 6H); 3.96 (s, 3H); 6.36 (d, J ) 2.3 Hz, 1H); 6.51 (d, J ) 2.3 Hz, 1H); 6.77 (d, J ) 8.9 Hz, 1H); 6.82 (s, 1H); 7.49 (d, J ) 8.9 Hz, 1H). 13C NMR (50 MHz, CDCl3) δ: 55.7; 56.1; 56.4; 61.0; 61.1; 92.8; 95.9; 107.3; 109.3; 112.7; 118.9; 123.8; 142.8; 152.9; 155.9; 158.7; 160.0; 161.0; 163.9; 177.9. 5,7-Dimethoxy-4′-triﬂuoromethoxyﬂavone (6{2,4}). 1H NMR (200 MHz, CDCl3) δ: 3.92 (s, 3H); 3.96 (s, 3H); 6.39 (d, J ) 2.2 Hz, 1H); 6.56 (d, J ) 2.2 Hz, 1H); 6.69 (s, 1H); 7.28-7.42 (m, 2H); 7.85-8.02 (m, 2H). 13C NMR (50 MHz, CDCl3) δ: 55.8; 56.4; 92.8; 96.3; 109.3; 102.3 (q, J ) 253.2 Hz); 121.1; 127.7; 130.0; 132.1; 151.3 (q, J ) 2.0 Hz); 159.4; 159.8; 161.0; 164.3; 177.5. 5,7-Dimethoxy-4′-piperonylﬂavone (6{2,5}).51 1H NMR (200 MHz, CDCl3) δ: 3.91 (s, 3H); 3.96 (s, 3H); 6.06 (s, 2H); 6.38 (d, J ) 1.1 Hz, 1H); 6.55 (d, J ) 1.1 Hz, 1H); 6.56 (s, 1H); 6.91 (d, J ) 4.2 Hz, 1H); 7.31 (d, J ) 1.0 Hz, 1H); 7.44 (dd, J ) 4.2, 1.0 Hz, 1H). 13C NMR (50 MHz, CDCl3) δ: 55.8; 56.5; 92.8; 96.2; 101,8; 106.1; 108.1; 108.7; 121.0; 125.6; 148.4; 150.3; 159.8; 160.4; 161.0; 162.0; 164.0; 177.6. 4′-Phenyl-5,7-dimethoxyﬂavone (6{2,6}). 1H NMR (200 MHz, CDCl3) δ: 3.93 (s, 3H); 3.96 (s, 3H); 6.38 (d, J ) 2.3 Hz, 1H); 6.59 (d, J ) 2.3 Hz, 1H); 6.72 (s, 1H); 7.35-7.54 (m, 3H); 7.57-7.82 (m, 4H); 7.87-8.05 (m, 2H). 13C NMR (50 MHz, CDCl3) δ: 55.8; 56.5; 92.9; 96.3; 109.0; 109.4; 126.4; 127.2; 127.6; 128.1; 129.0; 130.4; 139.9; 144.0; 160.0; 160.5; 161.0; 164.2; 177.7. 6-Fluoro-4′-methoxyﬂavone (6{3,1}).52 1H NMR (200 MHz, CDCl3) δ: 3.90 (s, 3H); 6.74 (d, J ) 0.6 Hz, 1H); Combinatorial Library of Chalcones and Flavones Journal of Combinatorial Chemistry, 2010 Vol. 12, No. 5 693 6.98-7.08 (m, 2H); 7.40 (ddd, J ) 9.1, 7.6, 3.1 Hz, 1H); 7.58 (ddd, J ) 9.1, 4.2, 0.5 Hz, 1H); 7.81-7.93 (m, 3H). 13C NMR (50 MHz, CDCl3) δ: 55.5; 105.5; 110.6 (d, J ) 23.9 Hz); 114.5; 119.9 (d, J ) 7.8 Hz); 121.6 (d, J ) 25.5 Hz); 123.8; 125.1 (d, J ) 5.8 Hz); 128.0; 152.4 (d, J ) 1.6 Hz); 159.6 (d, J ) 246.6 Hz); 162.6; 163.7; 177.5 (d, J ) 2.5 Hz). 6-Fluoro-2′,4′-dimethoxyﬂavone (6{3,2}). mp: 162- 164 °C. 1H NMR (200 MHz, CDCl3) δ: 3.89 (s, 3H); 3.92 (s, 3H); 6.55 (d, J ) 2.4 Hz, 1H); 6.63 (dd, J ) 8.8, 2.4 Hz, 1H); 7.13 (d, J ) 0.5 Hz, 1H); 7.37 (ddd, J ) 9.1, 7.6, 3.1 Hz, 1H); 7.51 (ddd, J ) 9.1, 4.3, 0.5 Hz, 1H); 7.85 (ddd, J ) 8.3, 3.1, 0.5 Hz, 1H); 7.87 (d, J ) 8.8 Hz, 1H). 13C NMR (50 MHz, CDCl3) δ: 55.5; 55.6; 98.9; 105.4; 110.4 (d, J ) 23.4 Hz); 110.5; 113.3; 119.8 (d, J ) 7.8 Hz); 121.3 (d, J ) 25.4 Hz); 124.9 (d, J ) 7.4 Hz); 130.7; 152.5 (d, J ) 2.0 Hz); 159.3 (d, J ) 244.2 Hz); 159.7; 161.1; 163.4; 178.0 (d, J ) 2.0 Hz). MS m/z: 300 (M+), 269, 214, 161, 139 (100), 119, 91, 65. IV (νmax, KBr): 1627, 1606, 1558, 1436, 1353, 1274, 1255, 1216, 1020, 811 cm-1. 6-Fluoro-2′,3′,4′-trimethoxyﬂavone (6{3,3}).53 1H NMR (200 MHz, CDCl3) δ: 3.92 (s, 3H); 3.95 (s, 3H); 3.96 (s, 3H); 6.81 (d, J ) 9.0 Hz, 1H); 7.00 (s, 1H); 7.39 (ddd, J ) 9.1, 7.6, 3.1 Hz, 1H); 7.52 (dd, J ) 9.1, 4.3 Hz, 1H); 7.55 (d, J ) 9.0 Hz, 1H); 7.87 (dd, J ) 8.2, 3.1 Hz, 1H). 13C NMR (50 MHz, CDCl3) δ: 56.2; 61.0; 61.2; 107.5; 110.5; 110.6 (d, J ) 24.0 Hz); 118.9; 120.0 (d, J ) 8.0 Hz); 121.6 (d, J ) 26.0 Hz); 124.1; 125.1; 143.0; 152.7; 153.2; 156.5; 159.5; (d, J ) 246.2 Hz); 161. 4′-Phenyl-6-ﬂuoroﬂavone (6{3,6}). 1H NMR (200 MHz, CDCl3) δ: 6.86 (s,1H); 7.35-7.55 (m, 4H); 7.56-7.72 (m, 3H); 7.72-7.82 (m, 2H); 7.88 (dd, J ) 8.1, 3.0 Hz, 1H); 7.95-8.03 (m, 2H). 13C NMR (50 MHz, CDCl3) δ: 106.7; 110.7 (d, J ) 23.5 Hz); 120.1 (d, J ) 8.2 Hz); 121.9 (d, J ) 25.6 Hz); 125.2 (d, J ) 7.4 Hz); 126.8; 127.1; 127.7; 128.3; 129.0; 130.3; 139.7; 144.6; 152.4 (d, J ) 1.6 Hz); 159.6 (d, J ) 247.0 Hz); 163.4; 177.5 (d, J ) 2.1 Hz). 4′,6-Dimethoxyﬂavone (6{4,1}).54 1H NMR (200 MHz, CDCl3) δ: 3.89 (s, 3H); 3.91 (s, 3H); 3.93 (s, 3H); 6.57 (d, J ) 2.3 Hz, 1H); 6.64 (dd, J ) 8.7, 2.3 Hz, 1H); 7.13 (s, 1H); 7.26 (dd, J ) 9.0, 3.1 Hz, 1H); 7.45 (d, J ) 9.0 Hz, 1H); 7.60 (d, J ) 3.1 Hz, 1H); 7.89 (d, J ) 8.7 Hz, 1H). 13C NMR (50 MHz, CDCl3) δ: 55.5; 55.9; 105.0; 105.6; 114.5; 119.4; 123.5; 124.2; 124.6; 128.0; 151.0; 157.0; 162.4; 163.2; 178.2. 2′,4′,6-Trimethoxyﬂavone (6{4,2}).55 1H NMR (200 MHz, CDCl3) δ: 3.89 (s, 3H); 3.91 (s, 3H); 3.93 (s, 3H); 6.57 (d, J ) 2.3 Hz, 1H); 6.64 (dd, J ) 8.7, 2.3 Hz, 1H); 7.13 (s, 1H); 7.26 (dd, J ) 9.0, 3.1 Hz, 1H); 7.45 (d, J ) 9.0 Hz, 1H); 7.60 (d, J ) 3.1 Hz, 1H); 7.89 (d, J ) 8.7 Hz, 1H). 13C NMR (50 MHz, CDCl3) δ: 55.5; 55.7; 56.0; 99.0; 104.8; 105.3; 110.6; 113.8; 119.3; 123.4; 124.4; 130.4; 151.3; 156.7; 159.6; 160.7; 163.2; 178.8. 2′,3′,4′,6-Tetramethoxyﬂavone (6{4,3}).56 1H NMR (200 MHz, CDCl3) δ: 3.92 (s, 3H); 3.94 (s, 3H); 3.96 (s, 3H); 6.80 (d, J ) 9.0 Hz, 1H); 6.98 (s, 1H); 7.27 (dd, J ) 9.1, 3.1 Hz, 1H); 7.45 (d, J ) 9.1 Hz, 1H); 7.54 (d, J ) 9.0 Hz, 1H); 7.61 (d, J ) 3.1 Hz, 1H). 13C NMR (50 MHz, CDCl3) δ: 56.0; 56.2; 61.0; 61.2; 104.9; 107.4; 110.5; 119.3; 119.4; 123.6; 124.1; 124.5; 142.9; 151.3; 153.1; 156.2; 156.9; 161.3; 178.6. 6-Methoxy-4′-triﬂuoromethoxyﬂavone (6{4,4}). 1H NMR (200 MHz, CDCl3) δ: 3.92 (s, 3H); 6.80 (s, 1H); 7.31 (dd, J ) 9.2, 3.1 Hz, 1H); 7.34-7.43 (m, 2H); 7.52 (d, J ) 9.2 Hz, 1H); 7.61 (d, J ) 3.1 Hz, 1H); 7.92-8.05 (m, 2H). 4′-Phenyl-6-methoxyﬂavone (6{4,6}). 1H NMR (200 MHz, CDCl3) δ: 3.92 (s, 3H); 6.88 (s, 1H); 7.30 (dd, J ) 9.1, 3.1 Hz, 1H); 7.40-7.44 (m, 2H); 7.45-7.57 (m, 2H); 7.62 (d, J ) 3.1 Hz, 1H); 7.63-7.70 (m, 2H), 7.72-7.82 (m, 2H); 7.97-8.07 (m, 2H). 13C NMR (50 MHz, CDCl3) δ: 56.0; 105.0; 106.8; 119.5; 123.8; 124.7; 126.7; 127.1; 127.7; 128.2; 129.0; 130.7; 139.8; 144.3; 151.1; 157.1; 163.0; 178.3. Inhibitory Activity Assay. Recombinant human cathepsin V was expressed and puriﬁed as described previously.57 The molar concentration of this enzyme was determined by active site titration with E-64. Kinetic measurements were carried out in a Molecular Devices Spectra MAX GEMINI XS. Stock solutions of the compounds were prepared at a concentration of 1 mM in DMSO, and the inhibitors were screened against the cathe- psin V at initial concentration of 25 µM. The protease inhibitor activity was carried out in triplicate in 96-well black plate with the method previously described by Barret et al.58 The reaction mixture contained 192 µL of a sodium acetate buffer (100 mM, 5 mM EDTA, 5 mM DTE, pH 5.5), 2 µL of 1 mM Z-Phe-Arg-MCA, 5 µL of sample, and 1 µL of cathepsin V (32 nM). The enzyme was activated during 5 min with DTE at 27 °C, after the solution was incubated during 5 min with the sample. The substrate was added to start the reaction, and the ﬂuorescence of 4-methyl-7- coumaryl-amide (release MCA) was measured at Ex 355 nm and Em 460 nm. Control assays were performed without inhibitor (negative control) and in the presence of the E-64 (positive control), an irreversible inhibitor for cysteine peptidase. Values of IC50 were determined by making rate measurements for at least seven inhibitor concentrations. Kinetics parameters were determined from collected data employing the SigmaPlot enzyme kinetics module. References and Notes (1) Yasuda, Y.; Li, Z.; Greenbaum, D.; Bogyo, M.; Weber, E.; Bro¨mme, D. J. Biol. Chem. 2004, 259, 36761–36770. (2) Somoza, J. R.; Zhan, H.; Bowman, K. K.; Yu, L.; Mortara, K. D.; Palmer, J. T.; Clark, J. M.; McGrath, M. E. Biochem- istry 2000, 39, 12543–12551. (3) (a) Mihelic, M.; Dobersek, A.; Guncar, G.; Turk, D. J. Biol. Chem. 2008, 283, 14453–14460. (b) Ong, P. C.; McGowan, S.; Pearce, M. C.; Irving, J. A.; Kan, W.-T.; Grigoryev, S. A.; Turk, B.; Silverman, G. A.; Brix, K.; Bottomley, S. P.; Whisstock, J. C.; Pike, R. N. J. Biol. Chem. 2007, 282, 36980– 36986. (c) Sabotic, J.; Popovic, T.; Puizdar, V.; Brzin, J. FEBS J. 2009, 276, 4334–4345. (4) Li, R.; Chen, X.; Gong, B.; Selzer, P. M.; Li, Z.; Davidson, E.; Kurzban, G.; Miller, R. E.; Nuzum, E. O.; McKerrow, J. H.; Fletterick, R. J.; Gillmor, S. A.; Craik, C. S.; Kuntz, I. D.; Cohen, F. E.; Kenyon, G. L. Bioorg. Med. Chem. 1996, 4, 1421–1427. (5) Li, R.; Kenyon, G. L.; Cohen, F. E.; Chen, X.; Gong, B.; Dominguez, J. N.; Davidson, E.; Kurzban, G.; Miller, R. E.; Nuzum, E. O.; Rosenthal, P. J.; Mckerrow, J. H. J. Med. Chem. 1995, 38, 5031–5037. 694 Journal of Combinatorial Chemistry, 2010 Vol. 12, No. 5 Alvim, Jr. et al. (6) Patil, A. D.; Freyer, A. J.; Killmer, L.; Offen, P.; Taylor, P. B.; Votta, B. J.; Johnson, R. K. J. Nat. Prod. 2002, 65, 624–627. (7) Pan, X.; Tan, N.; Zeng, G.; Zhanga, Y.; Jiaa, R. Bioorg. Med. Chem. 2005, 13, 5819–5825. (8) Zeng, G.-Z.; Pan, X.-L.; Tan, N.-H.; Xiong, J.; Zhang, Y.-M. Eur. J. Med. Chem. 2006, 41, 1247–1252. (9) Bauvois, B.; Puiffe, M.-L.; Bongui, J.-B.; Paillat, S.; Monneret, C.; Dauzonne, D. J. Med. Chem. 2003, 46, 3900–3913. (10) Brueggemeier, R. W.; Gu, X. J.; Mobley, J. A.; Joomprabutra, S.; Bhat, A. S.; Whetstone, J. L. Ann. N.Y. Acad. Sci. 2001, 948, 51–66. (11) Powers, D. G.; Casebier, D. S.; Fokas, D.; Ryan, W.; Troth, J. R.; Coffen, D. L. Tetrahedron 1998, 54, 4085–4096. (12) Ansari, F. L.; Nazir, S.; Noureen, H.; Mirza, B. Chem. BiodiVers. 2005, 2, 1656–1664. (13) Ullah, A.; Ansari, F. L.; Ihsan-ul-Haq; Nazir, S.; Mirza, B. Chem. BiodiVers 2007, 4, 203–214. (14) Galietta, L. J. V.; Springsteel, M. F.; Eda, M.; Niedzinski, E. J.; By, K.; Haddadin, M. J.; Kurth, M. J.; Nantz, M. H.; Verkman, A. S. J. Biol. Chem. 2001, 276, 19723–19728. (15) Marder, M.; Viola, H.; Bacigaluppo, J. A.; Colombo, M. I.; Wasowski, C.; Wolfman, C.; Medina, J. H.; Ruveda, E. A.; Paladini, A. C. Biochem. Biophys. Res. Commun. 1998, 249, 481–485. (16) Borman, S. Chem. Eng. News 2001, 79 (35), 49–58. (17) Hall, D. G.; Manku, S.; Wang, F. J. Comb. Chem. 2001, 3, 125–150. (18) Horton, D. A.; Bourne, G. T.; Smythe, M. L. Chem. ReV. 2003, 103, 893–930. (19) Ziegert, R. E.; Tora¨ng, J.; Knepper, K.; Bra¨se, S. J. Comb. Chem. 2005, 7, 148–169. (20) Nicoloau, K. C.; Pfefferkorn, J. A.; Roecker, A. J.; Cao, G. Q.; Barluenga, S.; Mitchell, H. J. Am. Chem. Soc. 2000, 122, 9939–9953. (21) Harikrishnan, L. S.; Showalter, H. D. H. Tetrahedron 2000, 56, 515–519. (22) Cheng, M. S.; Li, R. S.; Kenyon, G. Chin. Chem. Lett. 2000, 11, 851–854. (23) Yao, N.; Song, A.; Wang, X.; Dixon, S.; Lam, K. S. J. Comb. Chem. 2007, 9, 668–676. (24) Arai, M. A.; Sato, M.; Sawada, K.; Hosoya, T.; Ishibashi, M. Chem. Asian J. 2008, 3, 2056–2064. (25) Brown, S. D.; Armstrong, R. W. J. Org. Chem. 1997, 62, 7076–7077. (26) Bhat, A. S.; Whetstone, J. L.; Brueggemeier, R. W. J. Comb. Chem. 2000, 2, 597–599. (27) Huang, X.; Tang, E.; Xu, W.; Cao, J. J. Comb. Chem. 2005, 7, 802–805. (28) Gallo, M. B. C.; Marques, A. S. F.; Vieira, P. C.; da Silva, M. F. G. F.; Fernandes, J. B.; Silva, M.; Guido, R. V.; Oliva, G.; Thiemann, O. H.; Albuquerque, S.; Fairlamb, A. H. Z. Naturforsch. C 2008, 63, 371–382. (29) Magalha˜es, A. F.; Ruiz, A. L. T. G.; Tozzi, A. M. G. A.; Magalha˜es, E. G. Phytochemistry 1999, 52, 1681–1685. (30) Bois, F.; Boumendjel, A.; Mariotte, A.; Conseil, G.; Petro, A. Bioorg. Med. Chem. 1999, 7, 2691–2695. (31) Kumazawa, T.; Kimura, T.; Matsuba, S.; Sato, S.; Onodera, J. Carb. Res. 2000, 329, 507–513. (32) (a) Raghavendra, M. S.; Lam, Y. Tetrahedron Lett. 2004, 45, 6129–6132. (b) Hu, Y.; Baudart, S.; Porco, J. A., Jr. J. Org. Chem. 1999, 64, 1049–1051. (33) Boumendjel, A.; Boccard, J.; Carrupt, P.-A.; Nicolle, E.; Blanc, M.; Geze, A.; Choisnard, L.; Wouessidjewe, D.; Matera, E.- L.; Dumontet, C. J. Med. Chem. 2008, 51, 2307–2310. (34) Simpson, T. H.; Benton, J. L. J. Chem. Soc. 1954, 4065– 4069. (35) Kim, H.; Lee, E.; Kim, J.; Jung, B.; Chong, Y.; Ahn, J.-H.; Lim, Y. Bioorg. Med. Chem. Lett. 2008, 18, 661–664. (36) Che, H.; Park, B. K.; Lim, H.; Kim, H. P.; Chang, H. W.; Jeong, J.-H.; Park, H. Bioorg. Med. Chem. Lett. 2009, 19, 74–76. (37) Li, Z.; Ngojeh, G.; DeWitt, P.; Zheng, Z.; Chen, M.; Lainhart, B.; Li, V.; Felpo, P. Tetrahedron Lett. 2008, 49, 7243–7245. (38) Al-Ani, H. A. M.; Dewick, P. M. Phytochemistry 1985, 24, 55–61. (39) Avila, H. P.; Smania, E. F. A.; Delle-Monache, F.; Smania, A., Jr. Bioorg. Med. Chem. 2008, 16, 9790–9794. (40) Khan, A. T.; Goswami, P. Tetrahedron Lett. 2005, 46, 4937– 4940. (41) Rao, Y. K.; Fang, S.-H.; Tzeng, Y.-M. Bioorg. Med. Chem. 2004, 12, 2679–2686. (42) Chang, C. T.; Chen, F. C.; Chen, T. S.; Hsu, K. K.; Ueng, T.; Hung, M. J. Chem. Soc. 1961, 3414–3417. (43) Joshi, K. C.; Jauhar, A. K. J. Indian Chem. Soc. 1962, 39, 463–468. (44) Forghieri, M.; Laggner, C.; Paoli, P.; Langer, T.; Manao, G.; Camici, G.; Bondioli, L.; Prati, F.; Costantino, L. Bioorg. Med. Chem. 2009, 17, 2658–2672. (45) Dao, T. T.; Chi, Y. S.; Kim, J.; Kim, H. P.; Kim, S.; Park, H. Bioorg. Med. Chem. Lett. 2004, 14, 1165–1167. (46) Alam, S. J. Chem. Sci. 2004, 116, 325–331. (47) Hsu, K. K.; Shi, J. Y. J. Chin. Chem. Soc. 1973, 20, 51–56. (48) Choi, S. Y.; Ha, T. Y.; Ahn, J. Y.; Kim, S. R.; Kang, K. S.; Hwang, I. K.; Kim, S. Planta Med. 2008, 74, 25–32. (49) Bose, G.; Mondal, E.; Khan, A. T.; Bordoloi, M. J. Tetrahe- dron Lett. 2001, 42, 8907–8909. (50) Hari-Kishore, P.; Vijaya-Bhaskar-Reddy, M.; Kesava-Reddy, M.; Gunasekar, D.; Caux, C.; Bodo, B. Phytochemistry 2003, 63, 457–461. (51) dos Santos, D. A. P.; Braga, P. A. C.; da Silva, M. F. G. F.; Fernandes, J. B.; Vieira, P. C.; Magalhaes, A. F.; Magalhaes, E. G.; Marsaioli, A. J.; Moraes, V. R. S.; Rattray, L.; Croft, S. L. J. Pharm. Pharmacol. 2009, 61, 257–266. (52) Lin, Y.-M.; Zhou, Y.; Flavin, M. T.; Zhou, L.-M.; Nie, W.; Chen, F.-C. Bioorg. Med. Chem. 2002, 10, 2795–2802. (53) Habsaoui, A.; Wallet, J.-C.; Gaydou, E. M. Magn. Reson. Chem. 1998, 36, 621–624. (54) Su, W. K.; Zhu, X. Y.; Li, Z. H. Org. Prep. Proc. Int. 2009, 41, 69–75. (55) Ayers, S.; Zink, D. L.; Mohn, K.; Powell, J. S.; Brown, C. M.; Murphy, T.; Brand, R.; Pretorius, S.; Stevenson, D.; Thomp- son, D.; Singh, S. B. Phytochemistry 2008, 69, 541–545. (56) Beutler, J. A.; Hamel, E.; Vlietinck, A. J.; Haemers, A.; Rajan, P.; Roitman, J. N.; Cardellina, J. H., II; Boyd, M. R. J. Med. Chem. 1998, 41, 2333–2338. (57) Bro¨mme, D.; Li, Z.; Barnes, M.; Mehler, E. Biochemistry 1999, 38, 2377–2385. (58) Barrett, A. J.; Kembhavi, A. A.; Brown, M. A.; Kirschke, H.; Knight, C. G.; Tamai, M.; Hanada, K. Biochem. J. 1982, 201, 189–198. CC100076K Combinatorial Library of Chalcones and Flavones Journal of Combinatorial Chemistry, 2010 Vol. 12, No. 5 695 